The CHU Dijon Bourgogne and the Swiss company Cascination are implementing, for the first time in France, an interventional radiology solution that uses innovative technology to treat certain cancers, especially digestive cancers. This innovation has just been awarded during the Francophone Radiology Days.
Implemented in Dijon since this summer, CAS-One® IR is a system that combines software to calculate and simulate the tumor ablation surgery to be performed and then to verify that the operation has been performed correctly using an accompanying arm. interventional radiologist.
This complete device has many advantages: a valid aid for the healthcare team, greater precision during the intervention and an immediate evaluation of the success of the treatment. For the patient it is the guarantee of a much shorter hospital stay and of the quality of the intervention from which he benefits.
Specifically, the software of the CAS-One® IR system is able to identify the lesion, evaluate the volume to be removed, precisely define the safety margin around the lesion and therefore the area to be treated as well as the access path.
An arm guides the interventional radiologist’s gesture for access to the lesion, guaranteeing a perfect trajectory towards the area to be treated. The software allows you to confirm the position of the needle and, thanks to a new scanner carried out a few minutes later, to verify the effectiveness of the intervention – if necessary it is possible to repeat the intervention on site. the result is not satisfactory, which will avoid recalling the patient. CAS-One® IR also allows you to work on lesions invisible to the scanner.
The first operation carried out with the Cascination company system was carried out in August for a thermal ablation of the liver. Since then, around ten interventions have been carried out with the support of the CAS-One® IR system. About ten radio operators, five doctors and two interns have been trained in its use. The implementation at CHU Dijon Bourgogne, the first plant in France to have one, was financed by the plant’s innovation fund at a cost of around €300,000.
The deployment of this innovative technology is the subject of a communication during the Francophone Radiology Days taking place from 7 to 10 October in Paris. Days during which the Cascination company was awarded the prize for innovation in the interventional radiology category.
“CAS-One® IR technology allows simulation, guidance of interventional gestures and confirmation of ablation at the same time. It offers us precision and efficiency. Patients who benefit from this solution are hospitalized for one or two days, against eight to nine days for surgical interventions, which contributes to their better quality of life, and presents much less risk of recurrence Supported by this system, interventional radiology constitutes a real alternative to surgery: non-invasive, it allows to treat without opening is less risky and contributes to a better quality of life for patients.”
Professor Romaric Loffroy, head of the imaging department, CHU Dijon Bourgogne
“Since this summer, the CHU Dijon Bourgogne, the first establishment to be equipped with this technology in France, has successfully performed several percutaneous procedures with the support of CAS-One® IR, which allows the fusion of MRI and CT images invisible lesions, excellent precision in ablation of deep tumors, relevant planning for nearby tumors and confirmation of Ablasure® ablation to immediately assess the success of treating tumors other than digestive tumors and will enable clinical research protocols.
Philippe Mathieu, French director of Cascination
Press release
